We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $127B
1-Year Est. Return 46.06%
This Fund
S&P 500
This Quarter Est. Return
+9.96%
1 Year Est. Return
+46.06%
3 Year Est. Return
+142.12%
5 Year Est. Return
+190.33%
10 Year Est. Return
+787.47%
AUM
$51.2B
AUM Growth
+$4.14B
Cap. Flow
+$2.35B
Cap. Flow %
4.58%
Top 10 Hldgs %
19.89%
Holding
3,234
New
648
Increased
710
Reduced
838
Closed
835

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$1.99B
2
MSFT icon
Microsoft
MSFT
+$522M
3
AMD icon
Advanced Micro Devices
AMD
+$511M
4
AMZN icon
Amazon
AMZN
+$318M
5
AAPL icon
Apple
AAPL
+$317M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$402M
2
MCD icon
McDonald's
MCD
+$375M
3
V icon
Visa
V
+$366M
4
META icon
Meta Platforms (Facebook)
META
+$319M
5
ADBE icon
Adobe
ADBE
+$272M

Sector Composition

Rank Sector Weight
1 Technology 19.66%
2 Healthcare 17.11%
3 Miscellaneous 15.83%
4 Consumer Discretionary 13.3%
5 Financials 8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DASH icon
1026
DoorDash
DASH
$86.9B
$4.64M 0.01%
60,652
+33,268
+121% +$2.21M
BABA icon
1027
CALL
Alibaba
BABA
$280B
$4.63M 0.01%
55,600
-71,800
-56% -$6.28M
OMCL icon
1028
Omnicell
OMCL
$1.55B
$4.63M 0.01%
62,900
+13,265
+27% +$895K
POST icon
1029
Post Holdings
POST
$3.73B
$4.62M 0.01%
+53,373
New +$4.68M
OBDC icon
1030
Blue Owl Capital
OBDC
$5.51B
$4.62M 0.01%
+344,152
New +$4.5M
MORF
1031
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$4.6M 0.01%
80,316
-7,484
-9% -$391K
KNSA icon
1032
Kiniksa Pharmaceuticals
KNSA
$6.01B
$4.58M 0.01%
325,542
-481,283
-60% -$6.44M
V icon
1033
CALL
Visa
V
$688B
$4.56M 0.01%
19,200
+4,200
+28% +$961K
EXEL icon
1034
Exelixis
EXEL
$14.3B
$4.56M 0.01%
238,557
-191,172
-44% -$3.68M
HASI icon
1035
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.06B
$4.55M 0.01%
+181,817
New +$4.76M
PTGX icon
1036
Protagonist Therapeutics
PTGX
$9.44B
$4.54M 0.01%
164,500
-1,201,580
-88% -$30.1M
CSTA.WS
1037
CALL
DELISTED
Constellation Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CSTA.WS
$4.54M 0.01%
416,663
ZUMZ icon
1038
Zumiez
ZUMZ
$299M
$4.54M 0.01%
272,380
+256,080
+1,571% +$4.28M
GSBD icon
1039
Goldman Sachs BDC
GSBD
$1.09B
$4.54M 0.01%
327,350
+61,292
+23% +$832K
WGS icon
1040
GeneDx Holdings
WGS
$2.56B
$4.54M 0.01%
761,159
+1
+0% +$8
PHYT.WS
1041
CALL
DELISTED
Pyrophyte Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
PHYT.WS
$4.53M 0.01%
425,200
COLM icon
1042
Columbia Sportswear
COLM
$2.95B
$4.53M 0.01%
58,675
-171,545
-75% -$13.8M
HHLA.WS
1043
CALL
DELISTED
HH&L Acquisition Co. Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HHLA.WS
$4.52M 0.01%
430,336
NTR icon
1044
Nutrien
NTR
$38.5B
$4.5M 0.01%
76,281
+64,581
+552% +$4.11M
LOCC
1045
DELISTED
Live Oak Crestview Climate Acquisition Corp.
LOCC
$4.5M 0.01%
439,162
-803,767
-65% -$8.18M
GTACW
1046
CALL
DELISTED
Global Technology Acquisition Corp. I Warrant
GTACW
$4.49M 0.01%
429,791
FIGS icon
1047
FIGS
FIGS
$2.27B
$4.48M 0.01%
541,735
+461,388
+574% +$3.51M
CMBT
1048
CMB.TECH NV
CMBT
$5.58B
$4.48M 0.01%
294,259
+101,236
+52% +$1.65M
CRWD icon
1049
CrowdStrike
CRWD
$215B
$4.46M 0.01%
121,516
+51,888
+75% +$1.81M
NFNT.WS
1050
CALL
DELISTED
Infinite Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
NFNT.WS
$4.45M 0.01%
421,440
-3,559
-0.8% -$495

Similar funds

Marshall Wace's Q2 2023 Portfolio in Review

As of Q2 2023, Marshall Wace held 3,234 positions worth $51.2B, up 8.8% from $47.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Marshall Wace deployed $2.35B of net new capital in Q2 2023, opening 648 new positions and adding to 710 existing holdings. Its largest new stake was iShares Core S&P 500 ETF: 4,713,944 shares worth $2.1B.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 14% a quarter earlier, followed by Healthcare and Miscellaneous.

On the sell side, the largest reduction was Gilead Sciences, an estimated $402M trimmed.

  • Marshall Wace's largest Q2 2023 buy was iShares Core S&P 500 ETF: 4,713,944 shares worth $2.1B.
  • Marshall Wace added most to Microsoft in Q2 2023, an estimated $522M increase.
  • Marshall Wace's biggest Q2 2023 reduction was Gilead Sciences, cutting an estimated $402M.
  • Marshall Wace fully exited Cloudflare in Q2 2023, selling an estimated $136M.
  • Marshall Wace's ten largest holdings make up 20% of its $51.2B portfolio in Q2 2023.
  • Marshall Wace opened 648 new positions and closed 835 in Q2 2023.
  • Marshall Wace's portfolio value rose 8.8% quarter-over-quarter to $51.2B.

Based on Marshall Wace's 13F filing for Q2 2023, filed 14 Aug 2023.